Reports of Injection Site Necrosis After 23-Valent Pneumococcal Vaccine Use.
作者信息
Day Brendan, Thompson Deborah, Mba-Jonas Adamma, Alimchandani Meghna
机构信息
Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
出版信息
JAMA Intern Med. 2023 Sep 1;183(9):1015-1016. doi: 10.1001/jamainternmed.2023.2146.
Abstract
摘要
相似文献
1
Reports of Injection Site Necrosis After 23-Valent Pneumococcal Vaccine Use.使用23价肺炎球菌疫苗后注射部位坏死的报告。
JAMA Intern Med. 2023 Sep 1;183(9):1015-1016. doi: 10.1001/jamainternmed.2023.2146.
2
Safety and tolerability of pneumococcal vaccines in children.
Expert Opin Drug Saf. 2016 Jun;15(6):777-85. doi: 10.1517/14740338.2016.1160056. Epub 2016 Mar 21.
3
Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations.成人研究人群中接种 13 价肺炎球菌结合疫苗后出现迟发性注射部位反应。
Hum Vaccin Immunother. 2018;14(8):1948-1956. doi: 10.1080/21645515.2018.1452576. Epub 2018 Apr 13.
4
Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands.荷兰引入10价肺炎球菌结合疫苗3年后的侵袭性肺炎球菌病
Emerg Infect Dis. 2015 Nov;21(11):2040-4. doi: 10.3201/eid2111.140780.
5
Bacterial Meningitis Due to Streptococcus pneumoniae in a 7-Month-Old Girl Who Received Three Doses of 13-Valent Pneumococcal Conjugate Vaccine.7 月龄女婴接受 3 剂 13 价肺炎球菌结合疫苗后发生肺炎链球菌性细菌性脑膜炎
J Nippon Med Sch. 2020;87(5):299-303. doi: 10.1272/jnms.JNMS.2020_87-510.
6
23-valent pneumococcal polysaccharide vaccine. WHO position paper.23价肺炎球菌多糖疫苗。世界卫生组织立场文件。
Wkly Epidemiol Rec. 2008 Oct 17;83(42):373-84.
7
Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Compared With 7-valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China.13价肺炎球菌结合疫苗与7价肺炎球菌结合疫苗在中国健康婴儿中的免疫原性和安全性比较
Pediatr Infect Dis J. 2016 Sep;35(9):999-1010. doi: 10.1097/INF.0000000000001248.
8
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan.13 价肺炎球菌结合疫苗在日本健康婴儿中的免疫原性和安全性。
Pediatr Infect Dis J. 2013 Sep;32(9):984-9. doi: 10.1097/INF.0b013e318293007e.
9
Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine among Mexican children.23 价肺炎球菌多糖疫苗在墨西哥儿童中的免疫原性。
Arch Med Res. 2012 Jul;43(5):402-5. doi: 10.1016/j.arcmed.2012.07.005. Epub 2012 Aug 3.
10
Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study.11 价和 12 价肺炎球菌/无乳链球菌蛋白 D 结合疫苗（11vPHiD-CV、12vPHiD-CV）在婴儿中的免疫原性和安全性：一项 II 期、随机、多中心研究的结果。
Vaccine. 2019 Jan 3;37(1):176-186. doi: 10.1016/j.vaccine.2018.07.023. Epub 2018 Jul 24.
引用本文的文献
1
Global and Regional Burden of Vaccine-Associated Erythema Multiforme and Their Related Vaccines, 1967-2023: An In-Depth Analysis of the World Health Organization Pharmacovigilance Database.1967 - 2023年全球及区域疫苗相关多形性红斑负担及其相关疫苗：世界卫生组织药物警戒数据库的深入分析
Med Princ Pract. 2025;34(1):25-38. doi: 10.1159/000541797. Epub 2024 Oct 4.
Zotero 插件